Veeva Systems and Roche Pharmaceuticals Strengthen Their Successful Partnership

Veeva Systems and Roche Pharmaceuticals Strengthen Their Partnership

On November 24, 2025, Veeva Systems (NYSE: VEEV) announced an exciting new chapter in its collaboration with Roche Pharmaceuticals. This extension of their partnership will see Roche implement Veeva’s Vault Customer Relationship Management (CRM) platform, designed to enhance external communications through advanced Artificial Intelligence (AI).

Peter Gassner, the CEO of Veeva, expressed pride at the continued partnership, stating, "Roche and Veeva have been working together for many years. We are honored to expand our partnership with Vault CRM and equip Roche's field teams with the next generation of AI-enabled CRM."

The strategic decision to enhance their collaboration not only reinforces the long-standing relationship between the two organizations, but also aims to leverage data and AI at their core. Roche's head of Digital & Technology, Wafaa Mamilli, emphasized the benefits of this upgraded CRM system, commenting, "We are thrilled to deepen our partnership with Veeva through the implementation of Vault CRM across our global pharmaceutical organization. This tool will help us create more personalized interactions and provide our teams with insights needed to better support healthcare professionals and patients."

Vault CRM is part of the broader Vault CRM Suite of applications that form the foundation for commercial operations. What sets this new CRM apart is the integration of Veeva AI, a sophisticated, agent-based AI system embedded in the Vault platform. The AI enhancements will include specialized AI agents tailored to specific Veeva applications. Among these upcoming features, the Veeva AI Agents for Vault CRM will be available by December 2025 and will include a free-text agent, a voice agent, a pre-call agent, and a media agent, designed to streamline operations and enhance customer engagement.

Veeva Systems is recognized globally for its cloud solutions tailored to the life sciences sector, providing cutting-edge software, data, and consulting services. Their commitment to innovation, product excellence, and customer success has garnered a diverse client base exceeding 1,500, consisting of both large biopharmaceutical companies and emerging biotech firms. As a Public Benefit Corporation, Veeva is dedicated to aligning the interests of all stakeholders, which include customers, employees, shareholders, and the communities in which they operate.

Looking ahead, the potential benefits of this expanded partnership between Veeva and Roche are vast. They are set to revolutionize how pharmaceutical companies engage with healthcare professionals, ensuring that the right information reaches the right people, at the right time. This is a vital aspect of improving healthcare outcomes as it enables more efficient communication tailored to the needs of individual practitioners. The integration of data-driven insights will usher in a newer era of customer relationship management in the pharmaceutical sector, marked by precision and personalization.

As the healthcare landscape continues to evolve, partnerships like this one position both Veeva and Roche to respond swiftly and effectively to changes, ensuring they remain leaders in innovation and service. With their collaborative efforts, they are not just enhancing their operational capabilities but also contributing significantly to better patient care and medical support processes.

For more information about Veeva Systems, you can visit their official website.

Conclusion

The strengthened partnership between Veeva Systems and Roche Pharmaceuticals stands as a testament to the importance of collaboration in the healthcare sector. With the introduction of Vault CRM, equipped with advanced AI capabilities, both organizations are poised to make significant strides in how they engage with healthcare professionals and support patient care globally.